Skip to main menu Skip to main content Skip to footer
neurotech logo Accessibility Menu
Healthcare Professionals
  • About Us
    • Our Team
      • Leadership Team
      • Medical Advisory Board
    • Careers
    • Contact Us
  • Our Product
  • Science & Technology
    • Publications
  • Clinical
  • Patients
  • News
  • Healthcare Professionals

News

Home » News

Media Contact

Monique Watson
m.smith@neurotechusa.com

Click to read Two-Year Intraocular Delivery of Ciliary Neurotrophic Factor by Encapsulated Cell Technology Implant

November 2, 2013

Two-Year Intraocular Delivery of Ciliary Neurotrophic Factor by Encapsulated Cell Technology Implant

Two-Year Intraocular Delivery of Ciliary Neurotrophic Factor by Encapsulated Cell Technology Implants in Patients with Chronic Retinal Degenerative Diseases by Kauper et al.

 Click to read James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals.

August 6, 2013

James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals.

 Click to read NT-501 Granted Orphan-Drug Designation for Macular Telangiectasia Type 2 (MacTel)

July 24, 2012

NT-501 Granted Orphan-Drug Designation for Macular Telangiectasia Type 2 (MacTel)

< 1 … 3 4
neurotech logo
About Us Science & Technology Clinical Patients Our Product News Careers Publications
Stay Connected
Linked
,
Twitter
,
Instagram
Contact Us
Main Phone Number
Phone Icon 401-333-3880
Headquarters
Map Pin Icon
900 Highland Corporate Drive,
Suite 101
Cumberland, RI 02864
Commercial Office
Map Pin Icon
75 Second Ave, Suite 700
Needham, MA 02494
Accessibility Statement | Compliance | Privacy Policy | Consumer Health Data Privacy Notice | Supplier Code of Conduct Policy | Terms and Conditions of Use Policy
© Neurotech Pharmaceuticals, Inc. 2026
Designed by Glacial Multimedia.
⇧
Neurotech Pharmaceuticals, Inc. is now part of Alcon